Table 1 Instances of use of TRIPS flexibilities by SADC countries 2001–2016
Country | Year | WTO Class | Type of flex | Product(s) | Disease | Royalty | Executed |
|---|---|---|---|---|---|---|---|
Angola | 2005 | LDC | Par7 | All meds | All | NA | Y |
Lesotho | 2004 | LDC | Par7 | ARVs | HIV/AIDS | NA | Y |
Lesotho | 2006 | LDC | Par7 | All meds | All | NA | Y |
Malawi | 2004 | LDC | Par7 | All meds | All | NA | Y |
Malawi | 2005 | LDC | Par7 | ARVs | HIV/AIDS | NA | Y |
Mozambique | 2005 | LDC | Par7 | ARVs | HIV/AIDS | NA | Y |
South Africa | 2003 | DC | CL | AZT, 3TC, AZT/3TC, NVP | HIV/AIDS | up to 5% | N |
Tanzania | 2008 | LDC | Par7 | All Meds | All | NA | Y |
Zambia | 2004 | LDC | CL | 3TC/D4T/NVP | HIV/AIDS | 2.5% | Y |
Zambia | 2004 | LDC | Par7 | ARVs + | HIV/AIDS + | NA | Y |
Zambia | 2006 | LDC | Par7 | ARVs + | HIV/AIDS + | NA | Y |
Zimbabwe | 2004 | DC | CL | ARVs | HIV/AIDS | NK | Y |
Zimbabwe | 2003 | DC | CL | ARVs + | HIV/AIDS + | NK | Y |
Zimbabwe | 2002 | DC | CL | ARVs + | HIV/AIDS + | NK | Y |
Zimbabwe | 2005 | DC | CL | ARVs + | HIV/AIDS | NK | Y |